Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / IMGN - ImmunoGen Q3 2021 Earnings Preview

IMGN - ImmunoGen Q3 2021 Earnings Preview

ImmunoGen Inc.
ImmunoGen (NASDAQ:IMGN) is scheduled to announce Q3 earnings results on Friday, October 29th, before market open. The consensus EPS Estimate is -$0.19 and the consensus Revenue Estimate is $19.03M (+4.6% Y/Y). Seeking Alpha contributor Avisol Capital Partners said that "ImmunoGen is a leader in antibody drug conjugate technology", and opined that "current lows make the stock interesting". ImmunoGen reported a wider second-quarter net loss, partly driven by an increase in research and development expenses, in July. Over the last 3 months, EPS estimates have seen 3 upward revisions and 2 downward. Revenue estimates have seen 3 upward revisions and 2 downward. The company's shares have fallen more than 10% year to  date.

For further details see:

ImmunoGen Q3 2021 Earnings Preview
Stock Information
Company Name: ImmunoGen Inc.
Stock Symbol: IMGN
Market: NASDAQ
Website: immunogen.com
Menu
IMGN IMGN Quote IMGN Short IMGN News IMGN Articles IMGN Message Board
Get IMGN Alerts

News, Short Squeeze, Breakout and More Instantly...